ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

Neurostimulation is the process of involving an implantable medical device to modulate and alter neural activities for therapeutic purposes. The implantable devices used for neurostimulation are referred to as neurostimulation devices or Neurostimulator. The neurostimulation device implantation process is minimally invasive, and the growing demand for such surgeries is expected to increase the market penetration rates of these devices.

ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

Asia Pacific Neurostimulation Device Market by  System (Spinal Cord Stimulators (Scs), Deep Brain Stimulators (Dbs), Sacral Nerve Stimulators (Sns), Vagus Nerve Stimulators (Vns), Gastric Electric Stimulator, Other System) by Applications (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Other Applications) by Geography.

Request free sample

Neurostimulation is the process of involving an implantable medical device to modulate and alter neural activities for therapeutic purposes. The implantable devices used for neurostimulation are referred to as neurostimulation devices or Neurostimulator. The neurostimulation device implantation process is minimally invasive, and the growing demand for such surgeries is expected to increase the market penetration rates of these devices. Improvements in healthcare infrastructure & the high prevalence of lifestyle diseases leading to increased surgeries and chronic disorders will be propelling market growth at a CAGR of 11.20% in the Asia Pacific region during the forecasting years of 2019-2027.

The growing confidence of physicians in the use of neurostimulation devices is also expected to enforce the market to progress. India neurostimulation device market is mainly driven owing to initiatives taken by the state governments, rising prevalence of stroke along with the initiatives taken by foreign private organizations operating in the country. According to the World Health Organization, the prevalence rate for stroke accounts for 58 per 100000 among the population of the country. The individuals aged above 55 years are more prone to be impacted strokes in the country which is fueling the demand & adoption of neurostimulation devices market in India.

Many companies are contending in the race to gain the maximum sum of profits. Some of them are Cogentix Medical Inc., St. Jude Medical Inc. (acquired by Abbott Laboratories), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Helius Medical Technologies, The Magstim Company Limited, Cyberonics Inc., Neuronetics Inc., Depuy Synthes Companies, Ekso Bionics Holding Inc., Medtronic PLC, Dr. Langer Medical GmBH, Ectron Limited, Nevro Corp. and Hocoma AG.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
      • PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • HIGH OCCURRENCE OF NEURO DISEASES
      • DEVELOPMENTS IN TECHNOLOGY
      • RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      • HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
      • INCREASING GERIATRIC POPULATION
      • FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
    • MARKET RESTRAINTS
      • HIGH PRICE OF NEUROMODULATION TREATMENT
      • SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
      • ANONYMOUS APPLIANCE OF SCS THERAPY
      • STRINGENT REGULATORY APPROVALS
    • MARKET OPPORTUNITIES
      • DEVELOPMENT OF INDICATION FOR SCS
      • INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
      • GROWING OCCURRENCE OF CHRONIC DISCOMFORT
    • MARKET CHALLENGES
      • OBTAINABILITY OF ALTERNATIVE THERAPY
      • SAFETY CONCERNS
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF RIVALRY
    • ESTIMATION ANALYSIS
      • INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
      • RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
      • RISING GERIATRIC POPULATION
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ALEVA NEUROTHERAPEUTICS SA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BOSTON SCIENTIFIC CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • COGENTIX MEDICAL INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CYBERONICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DEPUY SYNTHES COMPANIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LANGER MEDICAL GMBH
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ECTRON LIMITED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • EKSO BIONICS HOLDING INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HELIUS MEDICAL TECHNOLOGIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HOCOMA AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MEDTRONIC PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEURONETICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEVRO CORP.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • THE MAGSTIM COMPANY LIMITED
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE  1       ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

TABLE  2       ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE  3       ASIA PACIFIC SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  4       ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  5       ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  6       ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  7       ASIA PACIFIC GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)

TABLE  8       ASIA PACIFIC OTHER SYSTEM MARKET 2019-2027 ($ MILLION)

TABLE  9       ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE  10     ASIA PACIFIC PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE  11     ASIA PACIFIC EPILEPSY MARKET 2019-2027 ($ MILLION)

TABLE  12     ASIA PACIFIC ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)

TABLE  13     ASIA PACIFIC URINARY AND FECAL INCONTINENCE  MARKET 2019-2027 ($ MILLION)

TABLE  14     ASIA PACIFIC DEPRESSION MARKET 2019-2027 ($ MILLION)

TABLE  15     ASIA PACIFIC DYSTONIA  MARKET 2019-2027 ($ MILLION)

TABLE  16     ASIA PACIFIC GASTROPARESIS MARKET 2019-2027 ($ MILLION)

TABLE  17     ASIA PACIFIC PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE  18     ASIA PACIFIC OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)

TABLE  19     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)

TABLE  20     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE  1     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  2     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)

FIGURE  3     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE  4     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE  5     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  6     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  7     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE  8     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE  9     ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)

FIGURE  10  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE  11  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY EPILEPSY  2019-2027 ($ MILLION)

FIGURE  12  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE  13  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE  2019-2027 ($ MILLION)

FIGURE  14  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE  15  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY DYSTONIA  2019-2027 ($ MILLION)

FIGURE  16  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE  17  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE  18  ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE  19  PORTER’S FIVE FORCE MODEL

FIGURE  20  PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)

FIGURE  21  RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)

FIGURE  22  VALUE CHAIN OF NEUROSTIMULATION DRUGS

FIGURE  23  INDIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  24  CHINA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  25  JAPAN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  26  AUSTRALIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  27  SOUTH KOREA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  28  REST OF ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  29  NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (%)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now